文献速递皮肤肿瘤

日光性角化病临床病程与潜在分子机制相关

The clinical course of actinic keratosis correlates with underlying molecular mechanisms.
PubMed 文献 · Br J Dermatol · 2019-09-11

该观察性队列研究对26例广泛光损伤患者进行3、6、9、11月随访,活检评估p53、E-cadherin、Snail、Slug和Twist。结论认为E-cadherin缺失和p53增加与AK持续、进展和消退的动态过程相关。

要点

  • Snail、Slug、Twist在AK中较日晒皮肤升高,与E-cadherin转录抑制相关。

核心结论

  • E-cadherin缺失和p53增加与AK持续、进展和消退的动态过程相关。

研究设计与样本

  • 观察性队列研究,纳入26例广泛光损伤患者。
  • 在第3、6、9、11月用透明塑料模板标测AK并随机选取预定AK活检。
  • 活检评估p53、E-cadherin、Snail、Slug和Twist,研究注册号NCT00027976。

主要发现

  • E-cadherin转录抑制因子Snail、Slug和Twist在AK中较日晒皮肤升高。

临床怎么用

  • E-cadherin、p53、Snail、Slug和Twist可作为潜在生物标志物评估化学预防药物疗效。
  • 针对这些分子的策略可能有助于逆转上升的皮肤癌发病率。

局限性

  • 组织学标志物测量并非主要终点。
  • 研究期间允许患者使用防晒霜。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Actinic keratoses (AKs) are common premalignant skin lesions triggered by excessive ultraviolet exposure. The majority of AKs regress or persist, but some progress to squamous cell carcinomas. Biomarkers associated with their persistence, progression and regression have not been characterized. OBJECTIVES: We performed skin biopsies in patients with extensive actinic damage to identify biomarkers that correlate with clinical progression and regression of AKs. METHODS: This was an observational study of a cohort of patients with extensive actinic damage. AKs were mapped on a clear plastic template in 26 patients at months 3, 6, 9 and 11. Biopsies were taken from randomly selected, predetermined AKs and were evaluated for p53, E-cadherin, Snail, Slug and Twist. The study is registered at Clinicaltrials.gov: NCT00027976. RESULTS: p53 exhibited greater expression in clinically apparent AKs (histological score 2·89 ± 1·45) than in regressed AKs (0·75 ± 0·96); P < 0·01. There was also significantly less membrane E-cadherin, the lack of which is a marker of epithelial-mesenchymal transition, in clinically apparent AKs (1·89 ± 1·81) than in sun-exposed skin (3·07 ± 1·75); P < 0·005. The E-cadherin transcription repressors Snail, Slug and Twist were increased in AKs compared with sun-exposed skin. A limitation of the study is that measurement of histological biomarkers was not a primary end point. In addition, patients were allowed to apply sunscreens. CONCLUSIONS: At the molecular level, loss of E-cadherin and an increase in p53 are linked to the dynamic interplay between the persistence, progression and regression of AKs. What's already known about this topic? Actinic keratoses (AKs) are common dysplastic epidermal lesions that result from chronic and excessive ultraviolet exposure. Biomarkers associated with progression and regression of AK have not been characterized. What does this study add? Decreased E-cadherin and increased p53, Snail, Slug and Twist (E-cadherin transcription factors) were associated with progression from AK to nonmelanoma skin cancer. What is the translational message? Strategies targeting these molecules may be effective in reversing rising skin cancer rates. E-cadherin, p53, Snail, Slug and Twist are potential biomarkers that may be used to assess the efficacy of existing chemopreventive agents.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Bakshi A, Shafi R, Nelson J, et al. The clinical course of actinic keratosis correlates with underlying molecular mechanisms. Br J Dermatol. 2019. PMID: 31299087. doi:10.1111/bjd.18338

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。